Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

In Brief for May 25, 2022

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

Using Comparative Effectiveness Data Based on Non-Randomized Study Designs to Support Regulatory, Reimbursement Decision-Making

In Measuring Outcomes, a Longer-Term View May be Needed

In Brief for June 8, 2022

Structure-Based Classification System for EGFR Mutations May Help Clinicians Personalize Treatments for More Patients

More Robust Tools Needed to Predict who will Respond to Immune Checkpoint Inhibitors

NACLC 22 Educational Session Explores the Rationale for Immune Checkpoint Inhibition

Growing Body of Evidence Highlights Potential Applications for Liquid Biopsy in Clinical Practice

When Perfect is the Enemy of Good: Investigators Compare Rigorous Clinical Trial Data to Real-World Experience

In Brief for Oct. 26, 2022